Abstract
This research study is about drug delivery systems. It provides readers with
relevant information, insights and analysis. This important medical
opportunity is assessed in terms of technical and business areas. The
participating companies are mapped to show where they fit in the industry
landscape. This study reviews the kinds of drug delivery systems that are
being used by pharma, biotech or medical device companies.
The report discusses the broad range of drug delivery systems, the technical
advances and the applications that drug makers might use. Key advances include
orally dissolving tablets and film strips, needle- and needle-free injection
systems, transdermal patches, transmucosal delivery, RNAi, drug-coated stents,
PEG, nanotechnology, liposomes, monoclonal antibodies, gene delivery, and
implants, which all contribute to the many ways that drugs or therapies can be
delivered. Drug delivery systems are reviewed in terms of approaches used for
delivering drugs targeting major diseases including cardiovascular, cancer,
asthma, diabetes, and the central nervous system among others.
This market study shows that drug delivery technologies can help drug makers
overcome some of their big challenges. The drug industry continues to see the
commercial demise of major branded drugs that reach their patent expiration
date. Billions of dollars in revenues are lost to generic drug makers each
year. The technology can be used as part of a 'line extension' strategy to
extend the commercial life of their profitable products. Drug delivery can
help 'rescue' drug projects with technical challenges by using a customized
delivery system.
This report discusses the above topics with interesting and useful findings.
The study estimates that the US drug delivery market value might reach nearly
$85 billion by 2010. The research includes over 235 key alliances and M&As
through 2006. This study uses 29 figures and tables to illustrate the findings
or trends. The profiles about companies important to the expanding drug
delivery market include detailed information about their business and
technical activities.
This report would benefit people with job titles including CEO, VPs, Director
of Business Development, Research Directors, Entrepreneurs, Venture
Capitalists, Investment Planners, Research Scientists, Consultants or Industry
Analysts.
| 
View Cart
